<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Prescription Drugs &#187; Captopril</title>
	<atom:link href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/feed" rel="self" type="application/rss+xml" />
	<link>http://www.prescriptiondrugs2go.com</link>
	<description>Popoular Prescription Drugs Latest News</description>
	<lastBuildDate>Fri, 10 Sep 2010 08:00:04 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>(E)-N-[(3,4-dimethoxyphenethyl)]-N-methyl-3-(3-pyridyl)-2-propenamide (TJN-331) inhibits mesangial expansion in experimental IgA nephropathy in ddY mice</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/e-n-34-dimethoxyphenethyl-n-methyl-3-3-pyridyl-2-propenamide-tjn-331-inhibits-mesangial-expansion-in-experimental-iga-nephropathy-in-ddy-mice.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/e-n-34-dimethoxyphenethyl-n-methyl-3-3-pyridyl-2-propenamide-tjn-331-inhibits-mesangial-expansion-in-experimental-iga-nephropathy-in-ddy-mice.html#comments</comments>
		<pubDate>Fri, 10 Sep 2010 07:40:15 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Captopril]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/e-n-34-dimethoxyphenethyl-n-methyl-3-3-pyridyl-2-propenamide-tjn-331-inhibits-mesangial-expansion-in-experimental-iga-nephropathy-in-ddy-mice.html</guid>
		<description><![CDATA[Conclusion&#160;&#160;These results suggest that TJN-331 is effective against IgA nephropathy in ddY mice and acts via suppression of TGF-Î²1 production
 in glomeruli.
	Content Type Journal ArticleDOI 10.1007/s10157-010-0338-4Authors
		Yayoi Saegusa, Division of Pharmasciences, Department of Pathophysiology and Therapeutics, Faculty of Pharmaceutical Sciences, Hokkaido University, N12 W6, Kita-ku, Sapporo, 060-0812 JapanChiharu Sadakane, Division of Pharmasciences, Department of Pathophysiology and Therapeutics, Faculty of Pharmaceutical Sciences, Hokkaido University, N12 W6, Kita-ku, Sapporo, 060-0812 JapanJunichi Koseki, Tsumura &#38; Co., Tsumura Research Laboratories, 3586 Yoshiwara, Ami-machi, Inashiki-gun, Ibaraki, 300-1192 JapanYoshihiro Hasegawa, Tsumura &#38; Co., Tsumura Research&#8230;

MedWorm Message: Register ...<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/e-n-34-dimethoxyphenethyl-n-methyl-3-3-pyridyl-2-propenamide-tjn-331-inhibits-mesangial-expansion-in-experimental-iga-nephropathy-in-ddy-mice.html">(E)-N-[(3,4-dimethoxyphenethyl)]-N-methyl-3-(3-pyridyl)-2-propenamide (TJN-331) inhibits mesangial expansion in experimental IgA nephropathy in ddY mice</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Conclusion&nbsp;&nbsp;These results suggest that TJN-331 is effective against IgA nephropathy in ddY mice and acts via suppression of TGF-Î²1 production<br />
 in glomeruli.</p>
<p>	Content Type Journal ArticleDOI 10.1007/s10157-010-0338-4Authors<br />
		Yayoi Saegusa, Division of Pharmasciences, Department of Pathophysiology and Therapeutics, Faculty of Pharmaceutical Sciences, Hokkaido University, N12 W6, Kita-ku, Sapporo, 060-0812 JapanChiharu Sadakane, Division of Pharmasciences, Department of Pathophysiology and Therapeutics, Faculty of Pharmaceutical Sciences, Hokkaido University, N12 W6, Kita-ku, Sapporo, 060-0812 JapanJunichi Koseki, Tsumura &amp; Co., Tsumura Research Laboratories, 3586 Yoshiwara, Ami-machi, Inashiki-gun, Ibaraki, 300-1192 JapanYoshihiro Hasegawa, Tsumura &amp; Co., Tsumura Research&#8230;
<div>
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/e-n-34-dimethoxyphenethyl-n-methyl-3-3-pyridyl-2-propenamide-tjn-331-inhibits-mesangial-expansion-in-experimental-iga-nephropathy-in-ddy-mice.html">(E)-N-[(3,4-dimethoxyphenethyl)]-N-methyl-3-(3-pyridyl)-2-propenamide (TJN-331) inhibits mesangial expansion in experimental IgA nephropathy in ddY mice</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/e-n-34-dimethoxyphenethyl-n-methyl-3-3-pyridyl-2-propenamide-tjn-331-inhibits-mesangial-expansion-in-experimental-iga-nephropathy-in-ddy-mice.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/renin-angiotensin-system-blockade-in-kidney-transplantation-a-systematic-review-of-the-evidence.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/renin-angiotensin-system-blockade-in-kidney-transplantation-a-systematic-review-of-the-evidence.html#comments</comments>
		<pubDate>Thu, 26 Aug 2010 07:40:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Captopril]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/renin-angiotensin-system-blockade-in-kidney-transplantation-a-systematic-review-of-the-evidence.html</guid>
		<description><![CDATA[Source: DARE
Area: Evidence &#62; Disease Focused Reviews
 CRD Summary: This review evaluated the effect of angiotensin-converting enzyme-inhibitor or angiotensin receptor blocker use following kidney transplantation. The authors found that treatment with an angiotensin-converting enzyme-inhibitor or angiotensin receptor blocker produced clinically conflicting results of reductions in proteinuria, haematocrit and glomerular filtration rate in renal transplant recipients. These conclusions seemed sufficiently cautious.
 [The included interventions were benazapril, candesartan, Captopril, enalapril, fosinopril, lisinopril, losartan, perindopril, quinapril, trandolapril and valsartan.]
 CRD Commentary: The research question was clear with supporting inclusion criteria for participants, interven&#8230;

MedWorm ...<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/renin-angiotensin-system-blockade-in-kidney-transplantation-a-systematic-review-of-the-evidence.html">Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Source: DARE<br />
Area: Evidence &gt; Disease Focused Reviews<br />
 CRD Summary: This review evaluated the effect of angiotensin-converting enzyme-inhibitor or angiotensin receptor blocker use following kidney transplantation. The authors found that treatment with an angiotensin-converting enzyme-inhibitor or angiotensin receptor blocker produced clinically conflicting results of reductions in proteinuria, haematocrit and glomerular filtration rate in renal transplant recipients. These conclusions seemed sufficiently cautious.<br />
 [The included interventions were benazapril, candesartan, <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril">Captopril</a>, enalapril, fosinopril, lisinopril, losartan, perindopril, quinapril, trandolapril and valsartan.]<br />
 CRD Commentary: The research question was clear with supporting inclusion criteria for participants, interven&#8230;
<div>
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/renin-angiotensin-system-blockade-in-kidney-transplantation-a-systematic-review-of-the-evidence.html">Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/renin-angiotensin-system-blockade-in-kidney-transplantation-a-systematic-review-of-the-evidence.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Captopril potentiates the anticonvulsant activity of carbamazepine and lamotrigine in the mouse maximal electroshock seizure model</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/captopril-potentiates-the-anticonvulsant-activity-of-carbamazepine-and-lamotrigine-in-the-mouse-maximal-electroshock-seizure-model.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/captopril-potentiates-the-anticonvulsant-activity-of-carbamazepine-and-lamotrigine-in-the-mouse-maximal-electroshock-seizure-model.html#comments</comments>
		<pubDate>Fri, 20 Aug 2010 09:00:20 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Captopril]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/captopril-potentiates-the-anticonvulsant-activity-of-carbamazepine-and-lamotrigine-in-the-mouse-maximal-electroshock-seizure-model.html</guid>
		<description><![CDATA[This study was accompanied by an evaluation of adverse
 effects of combined treatment with Captopril and antiepileptic drugs in the passive avoidance task and chimney test. Captopril
 (25 and 50&#160;mg/kg i.p.) did not influence the threshold for electroconvulsions. Among the tested antiepileptics, Captopril
 (25 and 50&#160;mg/kg i.p.) potentiated the antiseizure action of CBZ, decreasing its ED50 value from 12.1 to 8.9 and 8.7&#160;mg/kg, respectively. Moreover, Captopril (50&#160;mg/kg i.p.) enhanced the anticonvulsant activity
 of LTG. ED50 value for LTG was lowered from 5.1 to 3.5&#160;mg/kg. The observed interactions between Captopril and ...<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/captopril-potentiates-the-anticonvulsant-activity-of-carbamazepine-and-lamotrigine-in-the-mouse-maximal-electroshock-seizure-model.html">Captopril potentiates the anticonvulsant activity of carbamazepine and lamotrigine in the mouse maximal electroshock seizure model</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>This study was accompanied by an evaluation of adverse<br />
 effects of combined treatment with <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril">Captopril</a> and antiepileptic drugs in the passive avoidance task and chimney test. <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril">Captopril</a><br />
 (25 and 50&nbsp;mg/kg i.p.) did not influence the threshold for electroconvulsions. Among the tested antiepileptics, <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril">Captopril</a><br />
 (25 and 50&nbsp;mg/kg i.p.) potentiated the antiseizure action of CBZ, decreasing its ED50 value from 12.1 to 8.9 and 8.7&nbsp;mg/kg, respectively. Moreover, <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril">Captopril</a> (50&nbsp;mg/kg i.p.) enhanced the anticonvulsant activity<br />
 of LTG. ED50 value for LTG was lowered from 5.1 to 3.5&nbsp;mg/kg. The observed interactions between <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril">Captopril</a> and CBZ or LTG were pharmacodynamic<br />
 in nature as <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril">Captopril</a> did not alter plasma and total brain concentrations of these antiepileptics. The combinati&#8230;
<div>
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/captopril-potentiates-the-anticonvulsant-activity-of-carbamazepine-and-lamotrigine-in-the-mouse-maximal-electroshock-seizure-model.html">Captopril potentiates the anticonvulsant activity of carbamazepine and lamotrigine in the mouse maximal electroshock seizure model</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/captopril-potentiates-the-anticonvulsant-activity-of-carbamazepine-and-lamotrigine-in-the-mouse-maximal-electroshock-seizure-model.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Renal effects of Mammea africana Sabine (Guttiferae) stem bark methanol/methylene chloride extract on L-NAME hypertensive rats</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/renal-effects-of-mammea-africana-sabine-guttiferae-stem-bark-methanolmethylene-chloride-extract-on-l-name-hypertensive-rats.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/renal-effects-of-mammea-africana-sabine-guttiferae-stem-bark-methanolmethylene-chloride-extract-on-l-name-hypertensive-rats.html#comments</comments>
		<pubDate>Sun, 15 Aug 2010 07:40:03 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Captopril]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/renal-effects-of-mammea-africana-sabine-guttiferae-stem-bark-methanolmethylene-chloride-extract-on-l-name-hypertensive-rats.html</guid>
		<description><![CDATA[Conclusions : The above results suggest that the methanol/methylene chloride extract of the stem bark of M. africana may protect kidney against renal dysfunction and further demonstrate that its antihypertensive effect does not depend on a diuretic or natriuretic activity. (Source: Indian Journal of Pharmacology)

MedWorm Message: Register for MedMatcha, MedWorm&#8217;s medical advertising network, and receive $5 free advertising.

Renal effects of Mammea africana Sabine (Guttiferae) stem bark methanol/methylene chloride extract on L-NAME hypertensive rats is a post from: Prescription Drugs
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/renal-effects-of-mammea-africana-sabine-guttiferae-stem-bark-methanolmethylene-chloride-extract-on-l-name-hypertensive-rats.html">Renal effects of Mammea africana Sabine (Guttiferae) stem bark methanol/methylene chloride extract on L-NAME hypertensive rats</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Conclusions : The above results suggest that the methanol/methylene chloride extract of the stem bark of M. africana may protect kidney against renal dysfunction and further demonstrate that its antihypertensive effect does not depend on a diuretic or natriuretic activity. (Source: Indian Journal of Pharmacology)
<div>
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/renal-effects-of-mammea-africana-sabine-guttiferae-stem-bark-methanolmethylene-chloride-extract-on-l-name-hypertensive-rats.html">Renal effects of Mammea africana Sabine (Guttiferae) stem bark methanol/methylene chloride extract on L-NAME hypertensive rats</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/renal-effects-of-mammea-africana-sabine-guttiferae-stem-bark-methanolmethylene-chloride-extract-on-l-name-hypertensive-rats.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Captopril improves osteopenia in ovariectomized rats and promotes bone formation in osteoblasts</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/captopril-improves-osteopenia-in-ovariectomized-rats-and-promotes-bone-formation-in-osteoblasts.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/captopril-improves-osteopenia-in-ovariectomized-rats-and-promotes-bone-formation-in-osteoblasts.html#comments</comments>
		<pubDate>Tue, 10 Aug 2010 10:00:05 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Captopril]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/captopril-improves-osteopenia-in-ovariectomized-rats-and-promotes-bone-formation-in-osteoblasts.html</guid>
		<description><![CDATA[Abstract&#160;&#160;The present study was designed to investigate the effects of Captopril, an angiotensin-converting enzyme inhibitor (ACEI),
 on bone loss in aged ovariectomized (OVX) rats and its impact on the differentiation of cultured primary osteoblasts. Ten-month-old
 female Spragueâ€“Dawley rats were used for the study. After 2&#160;months post ovariectomy (OVX), the rats were treated with Captopril
 (1 or 5&#160;mg/kg/day, respectively) for another 2&#160;months. At endpoint, trabecular bone of the fourth lumbar vertebrae (L4) was
 undecalcified and examined by bone histomorphometry; the fifth lumbar vertebrae (L5) were examined by compression test. Primary
 osteoblasts ...<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/captopril-improves-osteopenia-in-ovariectomized-rats-and-promotes-bone-formation-in-osteoblasts.html">Captopril improves osteopenia in ovariectomized rats and promotes bone formation in osteoblasts</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Abstract&nbsp;&nbsp;The present study was designed to investigate the effects of <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril">Captopril</a>, an angiotensin-converting enzyme inhibitor (ACEI),<br />
 on bone loss in aged ovariectomized (OVX) rats and its impact on the differentiation of cultured primary osteoblasts. Ten-month-old<br />
 female Spragueâ€“Dawley rats were used for the study. After 2&nbsp;months post ovariectomy (OVX), the rats were treated with <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril">Captopril</a><br />
 (1 or 5&nbsp;mg/kg/day, respectively) for another 2&nbsp;months. At endpoint, trabecular bone of the fourth lumbar vertebrae (L4) was<br />
 undecalcified and examined by bone histomorphometry; the fifth lumbar vertebrae (L5) were examined by compression test. Primary<br />
 osteoblasts were isolated from the calvaria of newborn rats and treated with different concentrations of <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril">Captopril</a> in a dif&#8230;
<div>
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/captopril-improves-osteopenia-in-ovariectomized-rats-and-promotes-bone-formation-in-osteoblasts.html">Captopril improves osteopenia in ovariectomized rats and promotes bone formation in osteoblasts</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/captopril-improves-osteopenia-in-ovariectomized-rats-and-promotes-bone-formation-in-osteoblasts.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The exenatide analogue AC3174 attenuates hypertension, insulin resistance, and renal dysfunction in Dahl salt-sensitive rats</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/the-exenatide-analogue-ac3174-attenuates-hypertension-insulin-resistance-and-renal-dysfunction-in-dahl-salt-sensitive-rats.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/the-exenatide-analogue-ac3174-attenuates-hypertension-insulin-resistance-and-renal-dysfunction-in-dahl-salt-sensitive-rats.html#comments</comments>
		<pubDate>Tue, 03 Aug 2010 13:00:05 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Captopril]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/the-exenatide-analogue-ac3174-attenuates-hypertension-insulin-resistance-and-renal-dysfunction-in-dahl-salt-sensitive-rats.html</guid>
		<description><![CDATA[Background:
Activation of glucagon-like peptide-1 (GLP-1) receptors improves insulin sensitivity and induces vasodilatation and diuresis. AC3174 is a peptide analogue with pharmacologic properties similar to the GLP-1 receptor agonist, exenatide. Hypothetically, chronic AC3174 treatment could attenuate salt-induced hypertension, cardiac morbidity, insulin resistance, and renal dysfunction in Dahl salt-sensitive (DSS) rats.
Methods:
DSS rats were fed low salt (LS, 0.3% NaCl) or high salt (HS, 8% NaCl) diets. HS rats were treated with vehicle, AC3174 (1.7 pmol/kg/min), or GLP-1 (25 pmol/kg/min) for 4 weeks via subcutaneous infusion. Other HS rats received Captopril (150 mg/kg/day) ...<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/the-exenatide-analogue-ac3174-attenuates-hypertension-insulin-resistance-and-renal-dysfunction-in-dahl-salt-sensitive-rats.html">The exenatide analogue AC3174 attenuates hypertension, insulin resistance, and renal dysfunction in Dahl salt-sensitive rats</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Background:<br />
Activation of glucagon-like peptide-1 (GLP-1) receptors improves insulin sensitivity and induces vasodilatation and diuresis. AC3174 is a peptide analogue with pharmacologic properties similar to the GLP-1 receptor agonist, exenatide. Hypothetically, chronic AC3174 treatment could attenuate salt-induced hypertension, cardiac morbidity, insulin resistance, and renal dysfunction in Dahl salt-sensitive (DSS) rats.<br />
Methods:<br />
DSS rats were fed low salt (LS, 0.3% NaCl) or high salt (HS, 8% NaCl) diets. HS rats were treated with vehicle, AC3174 (1.7 pmol/kg/min), or GLP-1 (25 pmol/kg/min) for 4 weeks via subcutaneous infusion. Other HS rats received <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril">Captopril</a> (150 mg/kg/day) or AC3174 plus <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril">Captopril</a>.<br />
Results:<br />
HS rat survival was improved by all treatments except GLP-1. Systolic blood p&#8230;
<div>
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/the-exenatide-analogue-ac3174-attenuates-hypertension-insulin-resistance-and-renal-dysfunction-in-dahl-salt-sensitive-rats.html">The exenatide analogue AC3174 attenuates hypertension, insulin resistance, and renal dysfunction in Dahl salt-sensitive rats</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/the-exenatide-analogue-ac3174-attenuates-hypertension-insulin-resistance-and-renal-dysfunction-in-dahl-salt-sensitive-rats.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Myocardial Calcification and Hypertension following Chronic Renal Failure and Ameliorative Effects of Furosemide and Captopril</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/myocardial-calcification-and-hypertension-following-chronic-renal-failure-and-ameliorative-effects-of-furosemide-and-captopril.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/myocardial-calcification-and-hypertension-following-chronic-renal-failure-and-ameliorative-effects-of-furosemide-and-captopril.html#comments</comments>
		<pubDate>Mon, 02 Aug 2010 07:41:20 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Captopril]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/myocardial-calcification-and-hypertension-following-chronic-renal-failure-and-ameliorative-effects-of-furosemide-and-captopril.html</guid>
		<description><![CDATA[Cardiology 2010;116:194Ã¢Â€Â“205 (DOI:10.1159/000315146) (Source: Karger Publishers)

MedWorm Message: Register for MedMatcha, MedWorm&#8217;s medical advertising network, and receive $5 free advertising.

Myocardial Calcification and Hypertension following Chronic Renal Failure and Ameliorative Effects of Furosemide and Captopril is a post from: Prescription Drugs
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/myocardial-calcification-and-hypertension-following-chronic-renal-failure-and-ameliorative-effects-of-furosemide-and-captopril.html">Myocardial Calcification and Hypertension following Chronic Renal Failure and Ameliorative Effects of Furosemide and Captopril</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Cardiology 2010;116:194Ã¢Â€Â“205 (DOI:10.1159/000315146) (Source: Karger Publishers)
<div>
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/myocardial-calcification-and-hypertension-following-chronic-renal-failure-and-ameliorative-effects-of-furosemide-and-captopril.html">Myocardial Calcification and Hypertension following Chronic Renal Failure and Ameliorative Effects of Furosemide and Captopril</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/myocardial-calcification-and-hypertension-following-chronic-renal-failure-and-ameliorative-effects-of-furosemide-and-captopril.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Augmented Cyclooxygenase-2 Effects on Renal Function During Varying States of Angiotensin II Activity.</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/augmented-cyclooxygenase-2-effects-on-renal-function-during-varying-states-of-angiotensin-ii-activity.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/augmented-cyclooxygenase-2-effects-on-renal-function-during-varying-states-of-angiotensin-ii-activity.html#comments</comments>
		<pubDate>Mon, 02 Aug 2010 07:40:06 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Captopril]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/augmented-cyclooxygenase-2-effects-on-renal-function-during-varying-states-of-angiotensin-ii-activity.html</guid>
		<description><![CDATA[Authors: Green T, Rodriguez J, Navar LG
    NSAID usage has long revealed renoprotective prostaglandin actions on the renal microvasculature during increased pressor hormone influence, but whether increased COX-2 expression supports prostaglandin vasodilatory influence by interfering with the actions of angiotensin II (AngII) remains unresolved. Therefore, we tested the hypothesis that COX-2 inhibition causes hemodynamic and excretory effects that are increased in proportion to AngII activity. In anesthetized Sprague-Dawley rats having augmented cortical COX-2 expression but different AngII activity, we conducted renal clearance experiments during acute inhibition of ...<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/augmented-cyclooxygenase-2-effects-on-renal-function-during-varying-states-of-angiotensin-ii-activity.html">Augmented Cyclooxygenase-2 Effects on Renal Function During Varying States of Angiotensin II Activity.</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Authors: Green T, Rodriguez J, Navar LG<br />
    NSAID usage has long revealed renoprotective prostaglandin actions on the renal microvasculature during increased pressor hormone influence, but whether increased COX-2 expression supports prostaglandin vasodilatory influence by interfering with the actions of angiotensin II (AngII) remains unresolved. Therefore, we tested the hypothesis that COX-2 inhibition causes hemodynamic and excretory effects that are increased in proportion to AngII activity. In anesthetized Sprague-Dawley rats having augmented cortical COX-2 expression but different AngII activity, we conducted renal clearance experiments during acute inhibition of COX-2 with nimesulide (NMSLD) and COX-1 with SC-560. One series received acute <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril">Captopril</a> either alone (aACEi; n=13) or in co&#8230;</p>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/augmented-cyclooxygenase-2-effects-on-renal-function-during-varying-states-of-angiotensin-ii-activity.html">Augmented Cyclooxygenase-2 Effects on Renal Function During Varying States of Angiotensin II Activity.</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/augmented-cyclooxygenase-2-effects-on-renal-function-during-varying-states-of-angiotensin-ii-activity.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The effects of poststroke captopril and losartan treatment on cerebral blood flow autoregulation in SHRsp with hemorrhagic stroke</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/the-effects-of-poststroke-captopril-and-losartan-treatment-on-cerebral-blood-flow-autoregulation-in-shrsp-with-hemorrhagic-stroke.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/the-effects-of-poststroke-captopril-and-losartan-treatment-on-cerebral-blood-flow-autoregulation-in-shrsp-with-hemorrhagic-stroke.html#comments</comments>
		<pubDate>Sun, 25 Jul 2010 07:40:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Captopril]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/the-effects-of-poststroke-captopril-and-losartan-treatment-on-cerebral-blood-flow-autoregulation-in-shrsp-with-hemorrhagic-stroke.html</guid>
		<description><![CDATA[Authors: John S Smeda
          &#38; Noriko Daneshtalab (Source: Journal of Cerebral Blood Flow)
The effects of poststroke captopril and losartan treatment on cerebral blood flow autoregulation in SHRsp with hemorrhagic stroke is a post from: Prescription Drugs
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/the-effects-of-poststroke-captopril-and-losartan-treatment-on-cerebral-blood-flow-autoregulation-in-shrsp-with-hemorrhagic-stroke.html">The effects of poststroke captopril and losartan treatment on cerebral blood flow autoregulation in SHRsp with hemorrhagic stroke</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Authors: John S Smeda<br />
          &amp; Noriko Daneshtalab (Source: Journal of Cerebral Blood Flow)</p>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/the-effects-of-poststroke-captopril-and-losartan-treatment-on-cerebral-blood-flow-autoregulation-in-shrsp-with-hemorrhagic-stroke.html">The effects of poststroke captopril and losartan treatment on cerebral blood flow autoregulation in SHRsp with hemorrhagic stroke</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/the-effects-of-poststroke-captopril-and-losartan-treatment-on-cerebral-blood-flow-autoregulation-in-shrsp-with-hemorrhagic-stroke.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Glomerular filtration rate measured by 51Cr-EDTA clearance: evaluation of captopril-induced changes in hypertensive patients with and without renal artery stenosis</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/glomerular-filtration-rate-measured-by-51cr-edta-clearance-evaluation-of-captopril-induced-changes-in-hypertensive-patients-with-and-without-renal-artery-stenosis.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/glomerular-filtration-rate-measured-by-51cr-edta-clearance-evaluation-of-captopril-induced-changes-in-hypertensive-patients-with-and-without-renal-artery-stenosis.html#comments</comments>
		<pubDate>Sun, 25 Jul 2010 07:40:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Captopril]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/glomerular-filtration-rate-measured-by-51cr-edta-clearance-evaluation-of-captopril-induced-changes-in-hypertensive-patients-with-and-without-renal-artery-stenosis.html</guid>
		<description><![CDATA[CONCLUSIONS: Captopril induced a decrease in the GFR that could be quantitatively measured with 51Cr-EDTA. The reduction is more pronounced in hypertensive patients with RAS. (Source: Clinics)

MedWorm Message: Register for MedMatcha, MedWorm&#8217;s medical advertising network, and receive $5 free advertising.

Glomerular filtration rate measured by 51Cr-EDTA clearance: evaluation of captopril-induced changes in hypertensive patients with and without renal artery stenosis is a post from: Prescription Drugs
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/glomerular-filtration-rate-measured-by-51cr-edta-clearance-evaluation-of-captopril-induced-changes-in-hypertensive-patients-with-and-without-renal-artery-stenosis.html">Glomerular filtration rate measured by 51Cr-EDTA clearance: evaluation of captopril-induced changes in hypertensive patients with and without renal artery stenosis</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>CONCLUSIONS: <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril">Captopril</a> induced a decrease in the GFR that could be quantitatively measured with 51Cr-EDTA. The reduction is more pronounced in hypertensive patients with RAS. (Source: Clinics)
<div>
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/glomerular-filtration-rate-measured-by-51cr-edta-clearance-evaluation-of-captopril-induced-changes-in-hypertensive-patients-with-and-without-renal-artery-stenosis.html">Glomerular filtration rate measured by 51Cr-EDTA clearance: evaluation of captopril-induced changes in hypertensive patients with and without renal artery stenosis</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/captopril/glomerular-filtration-rate-measured-by-51cr-edta-clearance-evaluation-of-captopril-induced-changes-in-hypertensive-patients-with-and-without-renal-artery-stenosis.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
